Use of zebrafish in chemical biology and drug discovery

Future Medicinal Chemistry

Volumn 5, Issue 17, 2013, Pages 2103-2116

  Das, Bhaskar C ^a,b,c   McCormick, Laura ^c   Thapa, Pritam ^a   Karki, Radha ^a   Evans, Todd ^c  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; CYCLOOXYGENASE 2 INHIBITOR; ESTRADIOL DERIVATIVE; GLYCOGEN SYNTHASE KINASE 3BETA; HEME OXYGENASE 1; HONOKIOL; ISOINDOLE DERIVATIVE; PYRAZOLOPYRIMIDINE DERIVATIVE; RETINOIC ACID; RIBOSOME PROTEIN; THALIDOMIDE; TRIAZINE;

ALZHEIMER DISEASE; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; CYTOTOXICITY; DRUG DEVELOPMENT; DRUG POTENCY; HEART DEVELOPMENT; HEMATOPOIETIC STEM CELL; HUMAN; INNATE IMMUNITY; LONG QT SYNDROME; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TERATOGENESIS; TOXICITY TESTING; ZEBRA FISH;

ANIMALS; DRUG DISCOVERY; HUMANS; MODELS, ANIMAL; PHARMACOLOGICAL PHENOMENA; TOXICITY TESTS; ZEBRAFISH;

EID: 84887968332     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.13.170     Document Type: Review

References (67)

1. Streisinger G, Walker C, Dower N., Knauber D, Singer F. Production of clones of homozygous diploid zebrafish (Brachydanio rerio). Nature 291(5813), 293-296 (1981). (Pubitemid 11083423)
2. Nüsslein-Volhard C. The zebrafish issue of development. Development 139(22), 4099-4103 (2012).
3. Karlsson J, Von Hofsten J, Olsson PE Generating transparent zebrafish: a refined method to improve detection of gene expression during embryonic development. Mar. Biotechnol. (NY) 3(6), 522-527 (2001). (Pubitemid 34115368)
4. Goldsmith P. Zebrafish as a pharmacological tool: the how, why and when. Curr. Opin. Pharmacol. 4(5), 504-512 (2004) (Pubitemid 40533012)
5. MacRae CA, Peterson RT Zebrafish-based small molecule discovery. Chem. Biol. 10(10), 901-908 (2003). (Pubitemid 37316907)
6. Delvecchio C, Tiefenbach J, Krause HM The zebrafish: a powerful platform for in vivo, HTS drug discovery. Assay Drug Dev. Technol. 9(4), 354-361 (2011).
7. Zon LI, Peterson RT in vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov. 4(1), 35-44 (2005). (Pubitemid 40109588)
8. Peterson RT. Discovery of therapeutic targets by phenotype-based zebrafish screens. Drug Discov. Today Technol. 1(1), 49-54 (2004). (Pubitemid 40197552)
9. Taylor KL, Grant NJ, Temperley N.D., Patton EE Small molecule screening in zebrafish: an in vivo approach to identifying new chemical tools and drug leads. Cell Commun. Signal. 8, 11 (2010).
10. Khersonsky SM, Jung DW, Kang TW et al. Facilitated forward chemical genetics using a tagged triazine library and zebrafish embryo screening. J. Am. Chem. Soc. 125(39), 11804-11805 (2003). (Pubitemid 37175399)
11. Camus S, Quevedo C, Menéndez S et al. Identification of phosphorylase kinase as a novel therapeutic target through high-throughput screening for anti-angiogenesis compounds in zebrafish. Oncogene 31(39), 4333-4342 (2012).
12. Wang C, Tao W, Wang Y et al. Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer. Eur. Urol. 58(3), 418-426 (2010).
13. North TE, Goessling W, Walkley CR et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 447(7147), 1007-1011 (2007). (Pubitemid 46975751)
14. Goessling W, North TE, Lord AM et al. APC mutant zebrafish uncover a changing temporal requirement for wnt signaling in liver development. Dev. Biol. 320(1), 161-174 (2008).
15. Goessling W, North TE, Loewer S et al. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 136(6), 1136-1147 (2009).
16. Ito T, Ando H, Suzuki T et al. Identification of a primary target of thalidomide teratogenicity. Science 327(5971), 1345-1350 (2010).
17. Duester G. Retinoic acid synthesis and signaling during early organogenesis. Cell 134(6), 921-931 (2008).
18. Voigt A, Zintl F. Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells. Med. Pediatr. Oncol. 40(4), 205-213 (2003). (Pubitemid 36222824)
19. Noy N. Between death and survival: retinoic acid in regulation of apoptosis. Annu. Rev. Nutr. 30, 201-217 (2010).
20. Das BC, McCartin K, Liu T.C., Peterson RT, Evans T. A forward chemical screen in zebrafish identifies a retinoic acid derivative with receptor specificity. PLoS One 5(4), e10004 (2010).
21. Smith PG, Bradley R. Bovine spongiform encephalopathy (BSE) and its epidemiology. Br. Med. Bull. 66, 185-198 (2003). (Pubitemid 37173502)
22. Will RG, Ironside JW, Hornlimann B, Zeidler M. Creutzfeldt-Jakob disease. Lancet 347(8993), 65-66 (1996).
23. Thompson MJ, Louth JC, Ferrara S et al. Discovery of 6-substituted indole-3-glyoxylamides as lead antiprion agents with enhanced cell line activity, improved microsomal stability and low toxicity. Eur. J. Med. Chem. 46(9), 4125-4132 (2011).
24. Plotkin B, Eldar-Finkelman H, Schmidt B. Structure-based optimization of oxadiazole-based GSK-3 inhibitors. Eur. J. Med. Chem. 61, 26-40 (2013).
25. Zou H, Zhou L, Li Y et al. Benzo[e] isoindole-1,3-diones as potential inhibitors of glycogen synthase kinase-3 (GSK-3). Synthesis, kinase inhibitory activity, zebrafish phenotype, and modeling of binding mode. J. Med. Chem. 53(3), 994-1003 (2010).
26. Xu Z, Li Y, Xiang Q et al. Design and synthesis of novel xyloketal derivatives and their vasorelaxing activities in rat thoracic aorta and angiogenic activities in zebrafish angiogenesis screen. J. Med. Chem. 53(12), 4642-4653 (2010).
27. Li ZX, Chen JW, Yuan F et al. Xyloketal B exhibits its antioxidant activity through induction of HO-1 in vascular endothelial cells and Zebrafish. Mar. Drugs 11(2), 504-522 (2013).
28. Ott I, Qian X, Xu Y et al. A gold(I) phosphine complex containing a naphthalimide ligand functions as a TrxR inhibiting antiproliferative agent and angiogenesis inhibitor. J. Med. Chem. 52(3), 763-770 (2009).
29. Radi M, Evensen L, Dreassi E et al. A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: from in silico screening to cyclodextrin formulation. Bioorg. Med. Chem. Lett. 22(17), 5579-5583 (2012).
30. Ma L, Chen J, Wang X et al. Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship. J. Med. Chem. 54(19), 6469-6481 (2011).
31. Hao J, Ho JN, Lewis JA et al. in vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem. Biol. 5(2), 245-253 (2010).
32. Fotsis T, Zhang Y, Pepper MS et al. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368(6468), 237-239 (1994). (Pubitemid 24108838)
33. Quezada M, Alvarez M, Peña OA et al. Antiangiogenic, antimigratory and antiinflammatory effects of 2-methoxyestradiol in zebrafish larvae. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 157(2), 141-149 (2013).
34. Gu J, Anumala UR, Lo Monte F et al. 2-styrylindolium based fluorescent probes visualize neurofibrillary tangles in Alzheimer's disease. Bioorg. Med. Chem. Lett. 22(24), 7667-7671 (2012).
35. Li Y, Huang W, Huang S., Du J, Huang C. Screening of anti-cancer agent using zebrafish: comparison with the MTT assay. Biochem. Biophys. Res. Commun. 422(1), 85-90 (2012).
36. Ciechanover A, Schwartz AL The ubiquitin system: pathogenesis of human diseases and drug targeting. Biochim. Biophys. Acta. 1695(1-3), 3-17 (2004). (Pubitemid 39574964)
37. Einsele H. Bortezomib. Recent Results Cancer Res. 184, 173-187 (2010).
38. Shen L, Au W Y, Guo T et al. Proteasome inhibitor bortezomib-induced apoptosis in natural killer (NK)-cell leukemia and lymphoma: an in vitro and in vivo preclinical evaluation. Blood 110(1), 469-470 (2007). (Pubitemid 47026871)
39. Chauhan D, Hideshima T, Anderson KC Proteasome inhibition in multiple myeloma: therapeutic implication. Annu. Rev. Pharmacol. Toxicol. 45, 465-476 (2005).
40. Zhu Y, Zhu X, Wu G et al. Synthesis, in vitro and in vivo biological evaluation, docking studies, and structure-activity relationship (SAR) discussion of dipeptidyl boronic acid proteasome inhibitors composed of b-amino acids. J. Med. Chem. 53(5), 1990-1999 (2010).
41. Selderslaghs I.W., Van Rompay AR, De Coen W, Witters HE Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo. Reprod. Toxicol. 28(3), 308-320 (2009).
42. Hermann AC, Millard PJ, Blake S.L., Kim CH Development of a respiratory burst assay using zebrafish kidneys and embryos. J. Immunol. Methods. 292(1-2),119-129 (2004). (Pubitemid 39185873)
43. Ho SY, Pack M, Farber SA Analysis of small molecule metabolism in zebrafish. Methods Enzymol. 364, 408-426 (2003). (Pubitemid 37408460)
44. Walters J.W., Anderson JL, Bittman R, Pack M., Farber SA Visualization of lipid metabolism in the zebrafish intestine reveals a relationship between NPC1L1-mediated cholesterol uptake and dietary fatty acid. Chem. Biol. 19(7), 913-925 (2012).
45. Shimada Y, Hirano M, Nishimura Y., Tanaka T. A high-throughput fluorescence-based assay system for appetite-regulating gene and drug screening. PLoS One 7(12), e52549 (2012).
46. Peal DS, Mills RW, Lynch SN et al. Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen. Circulation 123(1), 23-30 (2011).
47. Le X, Pugach EK, Hettmer S et al. A novel chemical screening strategy in zebrafish identifies common pathways in embryogenesis and rhabdomyosarcoma development. Development 140(11), 2354-2364 (2013).
48. Wittmann C, Reischl M, Shah A.H., Mikut R., Liebel U, Grabher C. Facilitating drug discovery: an automated high-content inflammation assay in zebrafish. J. Vis. Exp. 65, e4203 (2012).
49. Choi W.Y., Gemberling M, Wang J et al. in vivo monitoring of cardiomyocyte proliferation to identify chemical modifiers of heart regeneration. Development 140(3), 660-666 (2013).
50. Mandal A, Rydeen A, Anderson J et al. Transgenic retinoic acid sensor lines in zebrafish indicate regions of available embryonic retinoic acid. Dev. Dyn. 242(8), 989-1000 (2013).
51. Barros TP, Alderton WK, Reynolds H.M., Roach AG, Berghmans S. Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery. Br. J. Pharmacol. 154 (7), 1400-1413 (2008).
52. Diekmann H, Hill A. ADMETox in zebrafish. Drug Discov. Today Dis. Models 10(1), e31-e35 (2013).
53. Alderton W, Berghmans S, Butler P et al. Accumulation and metabolism of drugs and CYP probe substrates in zebrafish larvae. Xenobiotica 40(8), 547-557 (2010).
54. Planchart A, Mattingly CJ 2,3,7,8-tetrachlorodibenzo-p-dioxin upregulates FoxQ1b in zebrafish jaw primordium. Chem. Res. Toxicol. 23(3), 480-487 (2010).
55. Milan DJ, Jones IL, Ellinor P.T., MacRae CA in vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation. Am. J. Physiol. Heart Circ. Physiol. 291(1), H269-H273 (2006).
56. Plavicki J, Hofsteen P, Peterson R.E., Heideman W. Dioxin inhibits zebrafish epicardium and proepicardium development. Toxicol. Sci. 131(2), 558-567 (2013).
57. Lee SH, Kim HR, Han R.X., Oqani RK, Jin DI Cardiovascular risk assessment of atypical antipsychotic drugs in a zebrafish model. J. Appl. Toxicol. 33(6), 466-470 (2013).
58. McGrath P, Li CQ Zebrafish: a predictive model for assessing drug-induced toxicity. Drug Discov. Today 13(9-10), 394-401 (2008).
59. Parng C, Roy NM, Ton C, Lin Y., McGrath P. Neurotoxicity assessment using zebrafish. J. Pharmacol. Toxicol. Methods. 55(1), 103-112 (2007). (Pubitemid 46048678)
60. Herrmann K. Teratogenic effects of retinoic acid and related substances on the early development of the zebrafish (Brachydanio rerio) as assessed by a novel scoring system. Toxic. In Vitro 9(3), 267-283 (1995).
61. Samson JC, Shenker J. The teratogenic effects of methylmercury on early development of the zebrafish, Danio rerio. Aquat. Toxicol. 48(2-3), 343-354 (2000). (Pubitemid 30109223)
62. Van Boxtel A.L., Kamstra JH, Fluitsma D.M., Legler J. Dithiocarbamates are teratogenic to developing zebrafish through inhibition of lysyl oxidase activity. Toxicol. Appl. Pharmacol. 244(2), 156-161 (2010).
63. Sişman T T, Geyikoǧlu F. The teratogenic effects of polychlorinated naphthalenes (PCNs) on early development of the zebrafish (Danio rerio). Environ. Toxicol. Pharmacol. 25(1), 83-88 (2008). (Pubitemid 350199005)
64. Stoletov K, Kato H, Zardouzian E et al. Visualizing extravasation dynamics of metastatic tumor cells. J. Cell Sci. 123(Pt 13), 2332-2341 (2010).
65. Ceol CJ, Houvras Y, Jane-Valbuena J et al. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature 471(7339), 513-517 (2011).
66. Bedell VM, Wang Y, Campbell JM et al. in vivo genome editing using a high-efficiency TALEN system. Nature 491(7422), 114-118 (2012).
67. Hwang WY, Fu Y, Reyon D et al. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat. Biotechnol. 31(3), 227-229 (2013).